Efficacy of octreotide in diarrhoea due to Vibrio cholerae: a randomized, controlled trial

REFERENCES

• Beubler, E., Kollar, G., Saria, A., Bukhave, K. & Rask-Madsen, J. (1989). Involvement of 5 hydroxytryptamine, prostaglandin E2, and cyclic adenosine monophosphate in cholera toxin induced secretion in the small intestine of rats in vivo. Gastroenterology, 96, 368–376.
   PubMed Web of Science ®Google Scholar
• Cooper, J. C., Williams, N. S., King, R. F. & Barker, M. C. (1986). Effects of a long acting somatostatin analogue in patients with severe ileostomy diarrhoea. British Journal of Surgery, 73, 128–131.
   PubMed Web of Science ®Google Scholar
• Dueno, M. I., Bai, J. C., Santoangelo, W. C. & Krejs, G. J. (1987). Effects of somatostatin analog on water and electrolyte transport and transit time in human small bowel. Digestive Diseases and Sciences, 32, 1092–1096.
   PubMed Web of Science ®Google Scholar
• Fedorak, R. N. & Allen, S. L. (1989). Effect of somatostatin analog (SMS 201–995) on in vivo intestinal fluid transport in rats. A limited systemic effect. Digestive Diseases and Sciences, 34, 567–572.
   PubMed Web of Science ®Google Scholar
• Field, M., Rao, M. C. & Chang, E. B. (1989). Intestinal electrolyte transport and diarrheal disease. New England Journal of Medicine, 321, 879–883.
   PubMed Web of Science ®Google Scholar
• Fine, K. D., Krejs, G. J. & Fordtran, J. S. (1989). Diarrhea. In Gastrointestinal Disease, Pathophysiology, Diagnosis, Management, eds Sleisenger, M. G. & Fordtran, J. S. pp. 290–316. Philadelphia: W. B. Saunders.
   Google Scholar
• Gilman, A. G. (1984). G proteins and dual control of adenylate cyclase. Cell, 36, 577–579.
   PubMed Web of Science ®Google Scholar
• Kimberg, D. V., Field, M., Johnson, J., Henderson, A. & Gershon, E. (1971). Stimulation of intestinal mucosal adenylate cyclase by cholera enterotoxin and prostaglandins. Journal of Clinical Investigation, 50, 1218–1230.
   PubMed Web of Science ®Google Scholar
• Lamers, C. B., Bijlstra, A. M. & Harris, A. G. (1993). Octreotide, a long acting somatostatin analog, in the management of post operative dumping syndrome. An update. Digestive Diseases and Sciences, 38, 359–364.
   PubMed Web of Science ®Google Scholar
• Manfredi, R., Vezzadini, P., Costigliola, P., Ricchi, E., Fanti, M. P. & Chiodo, F. (1993). Elevated plasma levels of vasoactive intestinal peptide in AIDS patients with refractory idiopathic diarrhoea. Effects of treatment with octreotide. AIDS, 7, 223–226.
   PubMed Web of Science ®Google Scholar
• Mihara, S., North, R,. A. & Surprenant, A. (1987). Somatostatin increases an inwardly rectifying potassium conductance. Journal of Physiology/, 300, 335–355.
   Web of Science ®Google Scholar
• Molla, A. M., Gyr, K., Bardhan, P. K. & Molla, A. (1984). Effect of intravenous somatostatin on stool output in diarrhea due to vibrio cholera. Gastroenterology, 87, 845–847.
   PubMed Web of Science ®Google Scholar
• Mourad, F. H., Gorard, D., Thillainayagam, A. V., Colin-Jones, D. & Farthing, M. J. (1992). Effective treatment of diabetic diarrhoea with somatostatin analogue, octreotide. Gut, 33, 1578–1580.
   PubMed Web of Science ®Google Scholar
• Oberg, K. (1993). Chemotherapy and bio-therapy in neuroendocrine tumors. Current Opinion in Oncology, 5, 110–120.
   PubMedGoogle Scholar
• Pawlotsky, J. M., Ruszniewshi, P., Reyl-Desmars, F., Bourgeois, M. & Lewin, M. J. (1993). Effects of PGE2 misoprostol and enprostile on guinea pig enterocyte adenylate cyclase. Clinical implication. Digestive Diseases and Sciences, 38, 316–320.
   PubMed Web of Science ®Google Scholar
• Reyl-Desmars, F., Laboisse, C. & Lewin, M. J. M. (1986). A somatostatin receptor negatively coupled to adenylate cyclase in the human gastric cell line HGT-1. Regulatory Peptides, 16, 207–215.
   PubMedGoogle Scholar
• Rosen, G. H. (1992). Somatostatin and its analogs in the short bowel syndrome. Nutrition in Clinical Practice, 7, 81–85.
   PubMedGoogle Scholar
• Ruskone, A., Rene, E., Chayvialle, J. A., Bonin, N., Pignal, F., Kremer, M., Bonfils, S. & Ramhaud, J. C. (1982). Effect of somatostatin on diarrhea and on small intestinal water and electrolyte transport in a patient with pancreatic cholera. Digestive Diseases and Sciences, 27, 459–466.
   PubMed Web of Science ®Google Scholar
• Sangangelo, W. C., O'Dorisio, T. M., Kim, J. G., Serverino, G. & Krejs, G. J. (1985). Pancreatic cholera syndrome: effect of a synthetic somatostatin analogue on intestinal water and ion transport. Annals of Internal Medicine, 103, 363–367.
   PubMed Web of Science ®Google Scholar
• Sjoqvist, A. (1992). Difference between the anti-secretory mechanisms of opioids and the somatostatin analogue octreotide in cholera toxin-induced small intestinal secretion in rat. Regulatory Peptides, 40, 339–349.
   PubMedGoogle Scholar
• Smid, W. M. & Dullaart, R. P. F. (1992). Octreotide for medullary thyroid carcinoma associated diarrhoea. Netherlands Journal of Medicine, 40, 240–243.
   PubMed Web of Science ®Google Scholar
• Spriggs, D. R. & Richard, L. G. (1993). Summary of the 27th United States-Japan Joint Conference on Cholera and Related Diarrheal Diseases. Journal of Infectious Diseases, 167, 1–6.
   PubMed Web of Science ®Google Scholar
• Walker, J. J. & Kaplan, D. S. (1993). Efficacy of the somatostatin analog octreotide in the treatment of two patients with refractory diabetic diarrhea. American Journal of Gastroenterology, 88, 765–767.
   PubMed Web of Science ®Google Scholar
• Wiley, J. & Owyang, C. (1987). Somatostatin inhibits cAMP-mediated cholinergic transmission in the myenteric plexus. American Journal of Physiology, 253, G607–G612.
   PubMed Web of Science ®Google Scholar
• Yoshioka, M., Asakura, H., Hamada, Y., Miura, S., Kobayashi, K, Morishita, T., Morita, A. & Tsuchiya, M. (1987). Inhibitory effect of somatostatin on cholera toxin-induced diarrhea and glycoenzyme secretion in rat intestine. Digestion, 36, 141–147.
   PubMed Web of Science ®Google Scholar